Evidence map›Paper›PMID 31804590›Full record

ArticleScientific reports2019

New Approaches for Quantitative Reconstruction of Radiation Dose in Human Blood Cells.

Shanaz A Ghandhi, Igor Shuryak, Shad R Morton, Sally A Amundson, David J Brenner

Abstract readValidation Study
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Biomarkers to Predict Lethal Radiation Injury to the Rat Lung.International journal of molecular sciences · 2023
    Article
  8. Review
  9. Transcriptomics for radiation biodosimetry: progress and challenges.International journal of radiation biology · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. The transcriptomic revolution and radiation biology.International journal of radiation biology · 2022
    Article
  15. Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Observational
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shanaz A GhandhiColumbia University Irving Medical Center, 630, W 168th street, VC11-237, New York, NY, 10032, USA. sg2423@cumc.columbia.edu.ORCID http://orcid.org/0000-0003-4199-0154
Igor ShuryakColumbia University Irving Medical Center, 630, W 168th street, VC11-237, New York, NY, 10032, USA.
Shad R MortonColumbia University Irving Medical Center, 630, W 168th street, VC11-237, New York, NY, 10032, USA.
Sally A AmundsonColumbia University Irving Medical Center, 630, W 168th street, VC11-237, New York, NY, 10032, USA.ORCID http://orcid.org/0000-0001-9992-8818
David J BrennerColumbia University Irving Medical Center, 630, W 168th street, VC11-237, New York, NY, 10032, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the event of a nuclear attack or large-scale radiation event, there would be an urgent need for assessing the dose to which hundreds or thousands of individuals were exposed. Biodosimetry approaches are being developed to address this need, including transcriptomics. Studies have identified many genes with potential for biodosimetry, but, to date most have focused on classification of samples by exposure levels, rather than dose reconstruction. We report here a proof-of-principle study applying new methods to select radiation-responsive genes to generate quantitative, rather than categorical, radiation dose reconstructions based on a blood sample. We used a new normalization method to reduce effects of variability of signal intensity in unirradiated samples across studies; developed a quantitative dose-reconstruction method that is generally under-utilized compared to categorical methods; and combined these to determine a gene set as a reconstructor. Our dose-reconstruction biomarker was trained using two data sets and tested on two independent ones. It was able to reconstruct dose up to 4.5 Gy with root mean squared error (RMSE) of ± 0.35 Gy on a test dataset using the same platform, and up to 6.0 Gy with RMSE of ± 1.74 Gy on a test set using a different platform.

Indexed as

Radiation DosageBiomarkersBlood CellsCivil DefenseComputational BiologyDatasets as TopicDose-Response Relationship, RadiationGene Expression ProfilingGene Expression RegulationHumansMass Casualty IncidentsOligonucleotide Array Sequence AnalysisProof of Concept StudyRadioactive Hazard ReleaseRadiometryTranscriptomeBiomarkers

Identifiers

PMID31804590
PMCPMC6895166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.